STCOSD
UTHR icon

Sageworth Trust Company of South Dakota’s United Therapeutics UTHR Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26
Closed -$6K – 630
2022
Q2 		$6K Hold
26
– – 0.01% 220
2022
Q1 		$5K Sell
26
-123
-83% -$23.4K 0.01% 302
2021
Q4 		$32K Buy
+149
New +$29.3K 0.05% 160

Other funds holding UTHR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Sageworth Trust Company of South Dakota's UTHR Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of United Therapeutics (UTHR) in Q3 2022, closing a stake of 26 shares — an estimated $6K sold.

Sageworth Trust Company of South Dakota first reported a position in UTHR in Q4 2021 and held it in 3 quarters. The position peaked at $32K in Q4 2021. 461 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining United Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 26 United Therapeutics shares in Q3 2022, an estimated $6K.
  • Sageworth Trust Company of South Dakota first reported a position in United Therapeutics in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's United Therapeutics position peaked at $32K in Q4 2021.
  • 461 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.